Joseph Chow - China Biologic Independent Director
Director
Mr. Joseph J. Chow is Independent Director of China Biologic Products, Inc. He has over 20 years of experience in corporate finance, financial advisory and management and has held senior executive and managerial positions in various public and private companies. Mr. Chow was recently a managing director of Moelis and Company and was previously a managing director at Goldman Sachs LLP. Prior to that, he served as an independent financial consultant, as chief financial officer of Harbor Networks Limited, and as chief financial officer of China Netcom Company Limited. Prior to that, Mr. Chow served as the director of strategic planning of Bombardier Capital, Inc., as vice president of international operations of Citigroup and as the corporate auditor of GE Capital. Mr. Chow currently sits on the board as a director for China Lodging Group, Limited, a company listed on NASDAQ Synutra International, Inc., a company listed on NASDAQ and an independent nonexecutive director for Intime Department Store Co., Ltd., a company listed on the Stock Exchange of Hong Kong since 2014.
| Age | 53 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | (86) 10 6598 3222 |
| Web | www.chinabiologic.com |
China Biologic Management Efficiency
The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David Sweet | Hooker Furniture | 69 | |
| Dennis McGillicuddy | Franklin Street Properties | 77 | |
| Paulette Garafolo | Hooker Furniture | 60 | |
| Edwin Ryder | Hooker Furniture | 69 | |
| Raymond Ritchey | Boston Properties | 73 | |
| Georgia Murray | Franklin Street Properties | 68 | |
| Daniel IV | Western Midstream Partners | N/A | |
| Daniel Brown | Western Midstream Partners | 42 | |
| Eric Butler | NiSource | 59 | |
| Jacob Frenkel | Boston Properties | 75 | |
| Bruce Duncan | Boston Properties | 68 | |
| Wallace Nutter | NiSource | 71 | |
| Craig Hatkoff | SL Green Realty | 66 | |
| David Twardock | Boston Properties | 63 | |
| Kelly Ayotte | Boston Properties | 52 | |
| Deborah Henretta | NiSource | 59 | |
| Larry Ryder | Hooker Furniture | 66 | |
| Kathryn ONeil | Franklin Street Properties | 55 | |
| Sigmund Cornelius | NiSource | 59 | |
| Kenneth Owen | Western Midstream Partners | 46 | |
| Brian Hansen | Franklin Street Properties | 47 | |
Management Performance
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 |
China Biologic Products Leadership Team
Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Fang, Director | ||
| Zhijing Liu, Corporate VP | ||
| Ming Yang, CFO | ||
| Joseph Chow, Independent Director | ||
| Gang Yang, Corporate VP and General Manager of Guizhou Taibang | ||
| Xiaosheng Shao, Independent Director | ||
| Ming Yin, Sr. Corporate VP and Corporate Secretary | ||
| Zhijun Tong, Independent Director | ||
| Yungang Lu, Independent Director | ||
| Wenfang Liu, Independent Director | ||
| Wai Yeung, Independent Director | ||
| David Li, Director | ||
| David Gao, Chairman of the Board and Presidentident, CEO | ||
| Xiaoying Gao, Executive Chairman, CEO and Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 | |||
| Profit Margin | 29.04 % | |||
| Operating Margin | 37.26 % | |||
| Current Valuation | 3.56 B | |||
| Shares Outstanding | 38.79 M | |||
| Shares Owned By Insiders | 45.08 % | |||
| Shares Owned By Institutions | 51.03 % | |||
| Number Of Shares Shorted | 781.13 K | |||
| Price To Earning | 31.41 X |
Pair Trading with China Biologic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Progressive Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Progressive Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Progressive Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Progressive Corp to buy it.
The correlation of Progressive Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Progressive Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Progressive Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Progressive Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |